Treatment of severe acute vascular rejection in a renal allograft with mycophenolate mofetil and high dose steroids

Scottish Medical Journal

Volumn 42, Issue 3, 1997, Pages 79-80

  Lafferty, M E ^a   Lang, S ^a   McGregor, E ^a   Henderson, I S ^a   Jones, M C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Mycophenolate mofetil; Renal allograft; Vascular rejection

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION;

EID: 0030785686     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693309704200305     Document Type: Article

References (4)

1. Rowe PA, Fan KS, Gardiner DS, Macpherson SG, Bradley JA Rodger RS, Junor BR, Briggs JD. Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transpl Int. 1994, 7 278-83.
2. Van der Woude FJ Mycophenolate mofetil (RS-61443): nothing new under the sun or an important break-through in the field of transplantation. Nephrol Dial Transplant 1995; 10: 1112-1114
3. Sollinger HW, Belzer FO, Deierhoi MH, Diethelm AG, Gonwa TA, Kauffman RS, Klintmalm GB, McDiarmid SV, Roberts J, Rosenthal JT, Tomianovich SJ. RS-61 443: rescue therapy in refractory kidney transplant rejection. Transplant Proc. 1993; 25: 698-99.
4. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation 1996; 61: 722-29.